COR Cencora
- 222.120
- +0.270+0.12%
- 221.850
- -0.270-0.12%
Cencora News
JPMorgan Adjusts Price Target on Cencora to $280 From $270
Cencora (COR) has an average rating of outperform and price targets ranging from $194 to $280, according to analysts polled by Capital IQ.
Here's How Much $1000 Invested In Cencora 5 Years Ago Would Be Worth Today
Cencora (NYSE:COR) has outperformed the market over the past 5 years by 9.3% on an annualized basis producing an average annual return of 22.36%. Currently, Cencora has a market capitalization of $44.
Health Care Is Still Very Crowded but Trades at a Discount Vs. History - BofA
The health care sector (NYSEARCA:XLV) is crowded despite a reversal on the recession outlook, according to BofA Securities’ Sector Focus Point report.
Cencora, Inc.'s (NYSE:COR) Share Price Matching Investor Opinion
With a price-to-earnings (or "P/E") ratio of 24.1x Cencora, Inc. (NYSE:COR) may be sending bearish signals at the moment, given that almost half of all companies in the United States have P/E ratios u
Express News | NYSE Order Imbalance 236367.0 Shares on Sell Side
Cencora To Host Inaugural ThinkLive Cell and Gene Therapy Summit
Cencora, a global healthcare company, will convene leaders from across the healthcare and biopharmaceutical industries for its inaugural ThinkLive Cell and Gene Therapy (CGT) Summit, an event designed to explore the latest developments in the CGT sector and strategies to accelerate product commercialization and patient access.
Jefferies Adjusts Price Target on Cencora to $230 From $235
Cencora (COR) has an average rating of outperform and price targets ranging from $194 to $280, according to analysts polled by Capital IQ. Price: 228.09, Change: +1.35, Percent Change: +0.60
Express News | Cencora Inc : Jefferies Cuts Target Price to $230 From $235
Form 144 | Cencora(COR.US) Insider Proposes to Sell 447.9K in Common Stocks
SEC FILLINGS DISCLOSED/ May 7, $AmerisourceBergen(ABC.US)$、$Cencora(COR.US)$ Insider Lon Greenberg intends to sell 2,000 shares of its common stock on May 7, with a total market value of approximately
Express News | Acclinate Raises $7M in Series a Funding to Accelerate Health Equity Revolution
Express News | NYSE Order Imbalance 57972.0 Shares on Sell Side
Cencora EVP Gina K. Clark Announces Amicable Retirement
Wells Fargo Adjusts Cencora Price Target to $236 From $235
Cencora (COR) has an average rating of outperform and price targets ranging from $194 to $280, according to analysts polled by Capital IQ. Price: 222.61, Change: -2.13, Percent Change: -0.95
Unveiling 4 Analyst Insights On Cencora
Throughout the last three months, 4 analysts have evaluated Cencora (NYSE:COR), offering a diverse set of opinions from bullish to bearish.The following table encapsulates their recent ratings, offeri
Research Alert: CFRA Maintains Hold View On Shares Of Cencora, Inc.
CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: Our 12-month target remains at $248, 16.
Express News | Cencora Inc : UBS Cuts Target Price to $275 From $277
Cardinal Health Lifts 2024 Profit View on Demand for Costly Specialty Drugs
Express News | Cencora Inc : TD Cowen Raises Target Price to $265 From $261
Cencora Is Maintained at Outperform by Baird
Cencora Is Maintained at Outperform by Baird
Express News | Baird Maintains Outperform on Cencora, Raises Price Target to $277
Analysis
Price Target
No Data
